<DOC>
	<DOCNO>NCT01556698</DOCNO>
	<brief_summary>The primary objective study compare tolerability , safety efficacy NVN1000 Topical Gel Topical Gel Vehicle treatment subject moderate severe acne vulgaris .</brief_summary>
	<brief_title>Study NVN1000 Topical Gel Topical Gel Vehicle Treatment Moderate Severe Acne Vulgaris</brief_title>
	<detailed_description />
	<mesh_term>Acne Vulgaris</mesh_term>
	<criteria>Baseline IGA score moderate ( 3 ) severe ( 4 ) Minimum 20 40 facial inflammatory lesion Minimum 20 60 facial noninflammatory lesion No 2 facial nodule Dermatological condition face could interfere clinical evaluation Underlying disease ( ) dermatological condition face require use interfere topical systemic therapy make evaluation lesion count inconclusive History experience significant burn sting apply facial treatment Female subject , pregnant , nursing mother , plan become pregnant study Have use estrogen oral contraceptive le 90 day immediately precede Baseline visit , discontinue use estrogens oral contraceptive le 90 day prior Baseline , plan begin discontinue use therapy treatment period Have use medication and/or vitamin report exacerbate acne 180 day immediately precede Baseline visit Use concomitantly overthecounter ( OTC ) product contain ingredient benzoyl peroxide , salicylic acid , alphahydroxy acid , retinol glycolic acid Have undergone specify washout topical preparation , systemic medication procedure note protocol</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Acne Vulgaris</keyword>
	<keyword>Acne</keyword>
</DOC>